North Branford, CT, United States of America

Paul Chen

This inventor holds 26 USPTO granted patents and 3 published patent applications and 2 EPO patents, primarily in Vehicle Automation. Top assignees: Neurogen Corporation, Foxconn Interconnect Technology Limited, Conexant Systems, Inc.. Active years: 1992-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Chen. Retrieved from https://idiyas.com/inventor/paul-chen-ypd1rw0o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 92.3


Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 344(Granted Patents)


Location History:

  • Champaign, IL (US) (1992 - 1995)
  • North Branford, CT (US) (1997 - 2001)
  • Thousand Oaks, CA (US) (2002)
  • Costa Mesa, CA (US) (2006 - 2009)
  • San Jose, CA (US) (2009)
  • Woodinville, WA (US) (2011)
  • Belmont, MA (US) (2015)
  • Venice, CA (US) (2013 - 2020)
  • Walnut, CA (US) (2017 - 2020)
  • Libertyville, IL (US) (2022)
  • Troy, MI (US) (2022)
  • Woodside, CA (US) (2023)

Company Filing History:


Years Active: 1992-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Autonomous Vehicles
Vehicle Summon
Thymoquinone
Liquid Sensor
Hybrid Transmission
Electrical Connector
GABA Ligands
Visual Simulation
Rotational Display
Web Content Management
26 patents (USPTO):Explore Patents

Title: Paul Chen: Innovator in Thymoquinone Compositions

Introduction: Paul Chen is an accomplished inventor based in Libertyville, IL, known for his innovative contributions to the field of pharmaceutical compositions. With a focus on the preparation of stable formulations of thymoquinone, Chen has developed methods that can impact therapeutic applications significantly.

Latest Patents: Chen holds one patent titled "Methods of preparing compositions containing thymoquinone." This invention revolves around creating stable preparations of thymoquinone and outlines various methods for making and administering these compositions. Specifically, the patent covers formulations that include thymoquinone with phosphatidylcholine, guggulsterol, guggulsterol derivatives, and sodium cholesteryl sulfate in various forms such as tablets, capsules, gels, or ointments.

Career Highlights: Currently, Paul Chen is associated with Jina Pharmaceuticals, Inc., where his work focuses on developing and improving pharmaceutical formulations. His expertise in stable composition preparation has contributed to advancing therapeutic options involving natural compounds.

Collaborations: Throughout his career, Chen has collaborated with notable professionals in the field, including Shoukath M Ali and Saifuddin Sheikh. These partnerships have fostered an environment conducive to innovation and have helped elevate the quality of their pharmaceutical offerings.

Conclusion: Paul Chen's dedication to innovation in the preparation of thymoquinone compositions exemplifies the intersection of research and practical application in pharmaceuticals. His patent and ongoing work at Jina Pharmaceuticals, Inc. highlight the importance of stability and efficacy in drug formulations. As an inventor, Chen continues to make significant strides in pharmaceutical sciences, making a positive impact on healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…